Downloads from IHEM 2022

Talks from IHEM 2022

Responsible for the content of the presentations is the respective speaker. No part of this publication may be reproduced without expressed written permission of the respective author or speaker, in any way reproduced or electronically processed, copied or distributed. The use of lectures and files is permitted only for the purpose of training and for personal use.

• SESSION 1: MOLECULAR – MPN PATHOGENESIS
  CHAIRS: A. Mullaly & M. Doubek
• A. Fleischman
  Clonal evolution
• R. Skoda
  Risk stratification
• SESSION 2: ET
  CHAIRS: T. Barbui & J. Schwarz
• A. Alvarez-Larrán
  Unmet need in ET
• R. Kušec
  How I treat
• M. Krauth
  Patient case IFN in ET
• SESSION 3: EARLY INTERVENTION IN PV – AIMING FOR DISEASE MODIFICATION
  CHAIRS: J. J Kiladjian & H. Gisslinger
• A. Mullaly
  Pre-clinical aspects
• T. Barbuih
  IFN guidelines
• M. Griesshammer
  Practical considerations
• SESSION 4: PATIENT CASES
  CHAIRS: V. Buxhofer-Ausch & A. Hatalová
• P. Schaffhausen
  Ropeg for low risk PV – Academic question or reality
• S. Papageorgiou
  Pre-treated PV
• M. Egyed
  CHIP patient
• T. Sliwa
  Switch patient case
• H. Gisslinger
  Combination therapy
• J. Göthert
  Efficacy of interferon in PV - A matter of dose?
• SESSION 5: CML – SET THE SCENE
  CHAIRS: A. Burchert & J. Góra-Tybor
• F. Stegelmann
  TKIs – A backbone with limitations
• A. Burchert
  IFN in CML – A critical review
• SESSION 7: OTHER MPN
  CHAIRS: D. Wolf & M. Egyed
• H. Gisslinger
  Pre-PMF Where are we heading to?
• V. Buxhofer-Ausch
  Pre-PMF patient cases
• MF. Passamonti
  MF – How I treat
• D. Wolf
  Secondary AML
• J.J Kiladjian
  New compounds